We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients (NEO-ZOTAC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01099436
Recruitment Status : Completed
First Posted : April 7, 2010
Last Update Posted : July 16, 2014
Information provided by (Responsible Party):